Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02621788 · ClinicalTrials.gov registry record · NA
Evaluation of Mind-body Educational Program to Enhance Resiliency and Reduce Burnout in First Year Residents
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT02621788: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02621788 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 85 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02621788, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
This prospective pilot study evaluated the benefits of a stress management and resiliency training program for residents (SMART-R). The primary objective of this study is to determine whether the SMART-R effectively reduces burnout and stress and enhances coping skills in first year residents. Objective parameters (heart rate, galvanized skin response, sleep duration and quality, exercise and actigraphy) measured with the Basis health tracking device will help correlate objective signs to subjective report of stress. The investigators' hypothesis is that the SMART-R, a curriculum designed to teach first year residents (in the department of Medicine and Psychiatry) relaxation skills, will enhance residents' emotional and physical well being, reduce reports of stress, anxiety, depression, and physical complaints, as well as increase overall resiliency.
Primary Outcome
Maslach Burnout Inventory (MBI), a validated 22-item self-report measure of professional burnout in human services. The MBI consists of 3 subscales of burnout: emotional exhaustion, depersonalization, and low sense of personal accomplishment.
Interventions
- BEHAVIORAL Stress Management and Resiliency Training for Residents (SMART-R)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-07 |
| Phase | NA |
What the finished NCT02621788 record still lists
NCT02621788 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Stress Management and Resiliency Training for Residents (SMART-R) is the first listed.
NCT02621788 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02621788 about?
NCT02621788 is a clinical study titled "Evaluation of Mind-body Educational Program to Enhance Resiliency and Reduce Burnout in First Year Residents". This prospective pilot study evaluated the benefits of a stress management and resiliency training program for residents (SMART-R). The primary objective of this study is to determine whether the SMART-R effectively reduces burnout and stress and enhances coping skills in first year residents. Obje...
What is the current status of trial NCT02621788?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2014-04. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02621788?
The interventions under investigation include: Stress Management and Resiliency Training for Residents (SMART-R) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02621788?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02621788's enrollment target sits among peer trials
85 980th of 2000 higher than 1,018 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia